Digital How GenAI is cracking the toughest targets in drug discovery Generative AI has the potential to solve for designing effective antibodies for G‑protein coupled receptors (GPCRs).
News Hippocratic AI builds in life sciences with Grove AI buy Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.
News Medscape launches genAI clinical support tool Medscape has joined the ranks of companies offering a generative AI chatbot to support clinical decision-making and help ease doctor workload.
Digital Towards one, cohesive AI workflow: In conversation with Ilya... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ilya Burkov, global head of healthcare & life sciences at Nebius, about AI.
Digital Implementing generative AI: A guide for commercial life scie... In a market saturated with articles highlighting the potential of generative AI, it’s crucial to also understand its limitations.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
